vimarsana.com

Latest Breaking News On - Farber cancer - Page 2 : vimarsana.com

Novel combination therapy shows promise in difficult-to-treat endometrial cancer, study finds

In a small, investigator-initiated phase 2 study by Dana-Farber Cancer Institute investigators, a novel combination of an antibody-drug conjugate and an immune checkpoint inhibitor showed notable activity in pre-treated patients with a difficult-to-treat form of endometrial cancer.

GENERATE study: Remote genetic education boosts testing rates for inherited cancer risk

vimarsana © 2020. All Rights Reserved.